يعرض 81 - 100 نتائج من 20,685 نتيجة بحث عن '(( 50 ng decrease ) OR ((( 50 ((ng decrease) OR (a decrease)) ) OR ( e non decrease ))))', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87

    The apparent Ca<sup>2+</sup> affinity of release is decreased by hydrophobic mutations. حسب Matthew R. Bowers (8423115)

    منشور في 2020
    "…The significant rightward shift in the curve (EC50, non overlapping confidence intervals) indicates a decrease in the apparent Ca<sup>2+</sup> affinity of neurotransmitter release.…"
  8. 88
  9. 89
  10. 90

    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. حسب Gui Araujo (22170819)

    منشور في 2025
    "…When they stop being introduced in further assembly events (i.e. introduced species do not carry any mutualistic interactions), their proportion slowly decreases with successive invasions. …"
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97

    Relationship between UCS, E, and water content. حسب Weisheng Zhao (3746023)

    منشور في 2025
    "…Based on the mechanical test results, reducing humidity can decrease the loss of uniaxial compressive strength (UCS) caused by moisture absorption from approximately 50% to 15.48%. …"
  18. 98
  19. 99

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation حسب Kairui Yue (11874403)

    منشور في 2022
    "…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …"
  20. 100

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation حسب Kairui Yue (11874403)

    منشور في 2022
    "…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …"